This review reveals oncofetal chondroitin sulfate's role in enhancing antibody-based therapy in cancer, suggesting potential for improved treatment outcomes.
Keywords: Antibody-based therapyCancerOncofetal-chondroitin sulfateTumor-associated carbohydratesTumor-microenvironmentTumor-stroma
No takes yet. Share an insight, caveat, or question.
Vidal-Calvo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: